Pages that link to "Q33996831"
Jump to navigation
Jump to search
The following pages link to PPAR agonists as direct modulators of the vessel wall in cardiovascular disease (Q33996831):
Displaying 10 items.
- Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation (Q24806958) (← links)
- The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases. (Q24814517) (← links)
- Role of Peroxisome Proliferator-Activated Receptor (PPAR)δ in Embryonic Stem Cell Proliferation. (Q33614818) (← links)
- Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. (Q34387386) (← links)
- Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets (Q35023612) (← links)
- Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor β. (Q36074920) (← links)
- PPAR-gamma agonists and diabetic nephropathy (Q36326399) (← links)
- PPARs: a new target for neuroprotection (Q42718625) (← links)
- Relationship between peroxisome proliferator-activated receptors (PPAR alpha and PPAR gamma) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats (Q43127490) (← links)
- Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-γ expression in splenic T cells (Q44414175) (← links)